Pushing bounds of cancer research

After developing a 20-year career in precision health care at world-renowned pharmaceutical companies, including Cambridge, Mass.-based Helicos Biosciences and Claritas Genomics, Patrice M. Milos decided to open Medley Genomics to push cancer research even further. “While we’re learning more about cancer, we’re still dealing with an often fatal disease,” said the president of the Providence-based…

You must be a subscriber to read this content. To keep reading and receive unlimited access subscribe today for only $1.
Subscribe Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.